Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
5-Year IF – 2.0, IF – 1.9, JCI (2024) – 0.43
Scopus CiteScore – 4.3
Q1 in SJR 2024, SJR score – 0.598, H-index: 49 (SJR)
ICV – 161.00; MNiSW – 70 pts
Initial editorial assessment and first decision within 24 h

ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2015, vol. 24, nr 6, November-December, p. 1013–1017

doi: 10.17219/acem/33824

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Attenuate Synovial Fluid Uncarboxylated Matrix Gla-Protein (ucMGP) Concentrations Are Linked with Radiographic Progression in Knee Osteoarthritis

Wu Bing1,A,B,C,D,E,F, Lin Feng1,A,B,C,D,E,F

1 Orthopedic Hospital, Chinese PLA General Hospital, Bejing, China

Abstract

Background. Decreased serum and synovial fluid (SF) uncarboxylated matrix Gla-protein (ucMGP) levels have been detected in OA patients. This study was carried out to investigate the association of serum and synovial fluid (SF) ucMGP levels with radiographic severity in knee OA patients.
Objectives. This study was carried out to investigate the association of serum and synovial fluid (SF) ucMGP levels with radiographic severity in knee OA patients.
Material and Methods. One hundred sewenty eight knee OA patients and 160 healthy controls among the outpatients in our hospital were enrolled in the study. Anteroposterior knee X-ray plains were taken to evaluate the radiographic severity of the affected knee. The radiographic assessment of knee OA was performed according to the Kellgren-Lawrence criteria. ucMGP levels in the serum and synovial fluid were examined utilizing enzyme-linked immunosorbent assay method (ELISA).
Results. The mean serum ucMGP levels of the knee OA patients was significantly lower than that of healthy controls [2603 (1919~3222) nmol/LVS 2811 (1926~3619) nmol/L, p = 0.045]. Synovial fluid (r = –0.479, p = 0.05) was negatively correlated with radiographic severity.
Conclusion. In conclusion, this study revealed a significant decrease in the SF ucMGP levels of OA patients and illustrated a negative correlation of SF ucMGP levels with the extent of radiographic severity in patients with knee OA. The present findings indicate that ucMGP in SF might serve as a novel biomarker for assessing OA progression.

Key words

osteoarthritis, radiographic severity, matrix Gla-protein

References (16)

  1. Michael JW, Schluter-Brust KU, Eysel P: The epidemiology, etiology, diagnosis, and treatment of osteoarthritis of the knee. Dtsch Arztebllnt 2010, 107, 152–162.
  2. Woolf AD, Pfleger B: Burden of major musculoskeletal conditions. Bull World Health Organ 2003, 81, 646–656.
  3. Patra D, Sandell LJ: Recent advances in biomarkers in osteoarthritis. Curr Opin Rheumatol 2011, 23, 465–470.
  4. Dominick J. Blasioli, David L. Kaplan: The roles of catabolic factors in the development of osteoarthritis. Tissue Eng Part B Rev 2013, 11, 1.
  5. Luo G, D’Souza R, Hogue D, Karsenty G: The matrix gla protein gene is a marker of the chondrogenesis cell lineage during mouse development. J Bone Miner Res 1995, 10, 325–334.
  6. Cranenburg EC, Vermeer C, Koos R, Boumans ML, Hackeng TM, Bouwman FG, Kwaijtaal M, Brandenburg VM, Ketteler M, Schurgers LJ: The circulating inactive form of matrix Gla Protein (ucMGP) as a biomarker for cardiovascular calcification. J Vasc Res 2008, 45, 427–436.
  7. Silaghi CN, Fodor D, Cristea V, Crăciun AM: Synovial and serum levels of uncarboxylated matrix Glaprotein( ucMGP)in patients with arthritis. Clin Chem Lab Med 2011, 50, 125–128.
  8. Yagami K, Suh JY, Enomoto-Iwamoto M: Matrix GLA protein is a developmental regulator of chondrocyte mineralization and, when constitutively expressed, blocks endochondral and intramembranous ossification in the limb. J Cell Biol 1999, 29, 1097–1108.
  9. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M: Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986, 29, 1039–1049.
  10. Kellgren JH, Lawrence JS: Radiological assessment of osteo-arthrosis.Ann Rheum Dis 1957, 16, 494–502.
  11. Ding C, Cicuttini F, Jones G: How important is MRI for detecting early osteoarthritis? Nat Clin Pract Rheumatol 2008, 4, 4–5.
  12. Takahashi M, Naito K, Abe M, Sawada T, Nagano A: Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis. Arthritis Res Ther 2004, 208–220.
  13. Goldring MB, Goldring SR: Osteoarthritis. J Cell Physiol 2007, 213, 626–634.
  14. Nagaosa Y, Lanyon P, Doherty M: Characterization of size and direction of osteophyte in knee osteoarthritis: a radiographic study. Ann Rheum Dis 2002, 61, 319–324.
  15. Hale JE, JD Fraser, PA Price: The identification of matrix Gla protein in cartilage. J Biol Chem 1998, 263, 5820– –5824.
  16. Misra D, Booth SL, Crosier MD: Matrix Gla protein polymorphism, but not concentrations, is associated with radiographic hand osteoarthritis. J Rheumatol 2011, 38, 1960–1965.
© Wroclaw Medical University